Olivia Lou

Impact of a Gluten-Free Diet on Quality of Life and Health Perception in Patients with Type 1 Diabetes and Asymptomatic Celiac Disease.

M. Lawson, S. Kirsch, C. McDonald, 2021, The Journal of clinical endocrinology and metabolism.

Continuous glucose monitoring Time-in-Range and HbA1c targets in pregnant women with type 1 diabetes.

A. de Leiva, C. Kollman, Julie A Taylor, 2021, Diabetes technology & therapeutics.

Quantifying the utility of islet autoantibody levels in the prediction of type 1 diabetes in children

W. Hagopian, J. Toppari, Kenney Ng, 2022, Diabetologia.

INnoVative trial design for testing the Efficacy, Safety and Tolerability of 6‐month treatment with incretin‐based therapy to prevent type 1 DIAbetes in autoantibody positive participants: A protocol for three parallel double‐blind, randomised controlled trials (INVESTDIA)

J. Toppari, R. Veijola, J. Kero, 2022, Diabetic medicine : a journal of the British Diabetic Association.

Islet autoantibody screening in at-risk adolescents to predict type 1 diabetes until young adulthood: a prospective cohort study.

W. Hagopian, J. Toppari, A. Ziegler, 2023, The Lancet. Child & adolescent health.

Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial

Michelle Perkins, Erin Keely, Lois E Donovan, 2017, The Lancet.

The Celiac Disease and Diabetes-Dietary Intervention and Evaluation Trial (CD-DIET) protocol: a randomised controlled study to evaluate treatment of asymptomatic coeliac disease in type 1 diabetes

M. Lawson, S. Kirsch, C. McDonald, 2015, BMJ Open.

Screening and Treatment Outcomes in Adults and Children With Type 1 Diabetes and Asymptomatic Celiac Disease: The CD-DIET Study

M. Lawson, S. Kirsch, C. McDonald, 2020, Diabetes Care.

Islet Autoantibody Levels Differentiate Progression Trajectories in Individuals With Presymptomatic Type 1 Diabetes

Bum Chul Kwon, W. Hagopian, J. Toppari, 2022, Diabetes.